In this episode, MM+M Pharma Editor Lecia Bushak sits down with Noom’s CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler to discuss the launch of their new Microdose GLP-1 program, designed ...

The MarketWatch News Department was not involved in the creation of this content. New program pairs microdoses of GLP-1 medication with Noom's powerful behavior-change program and at-home biomarker ...

70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Plenty of evidence shows that GLP-1 medications can help people manage type 2 diabetes and/or obesity. Drugs like Ozempic work by mimicking the hormone that releases insulin from your pancreas, ...

Online health platform Noom recently launched its Noom Microdose GLP-1 Rx Program to reportedly address barriers to GLP-1s, including medication cost. Over the last few years, the popularity of ...

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Noom, the leading platform for preventive health, today announced a free tier of its acclaimed wellness app and introduced Rebel Wilson as its Chief ...

SALT LAKE CITY, Dec. 17, 2025 /PRNewswire/ -- Shed, the wellness brand known for health and weight-loss solutions, has launched three new products to support long-term health: Tirzepatide Microdose ...

Microdose GLP-1 medication — eligible patients are prescribed small, personalized doses, which are conveniently shipped to the member’s door. At-home Biomarkers test kit — 17 advanced lab markers that ...

New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.